ChoA Pharmaceutical Receives Inquiry on Significant Price Fluctuation, Potential for Increased Volatility

The KOSDAQ Market Division has requested an inquiry disclosure regarding the significant price fluctuation of ChoA Pharmaceutical.
This action reflects market concerns over recent sharp price movements. The company must respond by 18:00 on June 24, 2026, stating whether any disclosure-triggering event exists.
No material events have been disclosed yet, and investors should be aware that volatility may increase depending on the response.
[AI Summary]The inquiry request for significant price fluctuation in ChoA Pharmaceutical signals potential short-term volatility; with no material event yet disclosed, investors should adopt a cautious approach until the response deadline.